Symptoms of chronic obstructive pulmonary disease (COPD) include breathlessness, coughing and/or wheezing. Activity monitors (e.g., apps or wearables) could support interventions to increase activity levels. This qualitative scoping review explored the experiences of people with COPD using technology for monitoring physical activity. Scientific databases were searched from 01/01/2016 to 16/03/2021 and twelve studies were included. Seven themes were developed using thematic synthesis: 1) Monitoring and keeping track of their activity and health, 2) Motivational tool to be active, 3) Acceptability of the device, 4) Experiencing technical issues with the device, 5) Appropriate and achievable goals for their health condition, 6) Integrating the device into their life and daily routine, and 7) Benefits of using the device. This review provides insight into how people with COPD experience monitoring technology. Further understanding is needed to explore how people with COPD use monitoring technology in everyday life and to help self-manage their condition.
Discover the world's research
20+ million members 135+ million publications 700k+ research projects Join for free
What are the e
with Chroni
Disease (COPD) using activity
monitors?:
A qualitativ
Laura J Wilde
Doctoral Capability and Developm
27th April 2022
www@laura
CHRONIC OBSTRUCT
DISEASE
•3rd leading cause of death worldwide
•Symptom
•Physical inactivity highly p
mental and ph
@laurawilde24
A
•Widely used in interventions
•Increase physical activity le
•Evidence is limited – can
active and a
@laurawilde24
AIM
T
experien
technology f
monitoring ph
activity among
people with COPD
within the published
literature
@laurawilde2
DA
SEARCHES
1st January 201–
16th March 2021
Extensiv
strategy
Screening: titles,
abstracts and full
te
@laurawilde2
INCLUSION
CRITERIA
Adults (18+)
Used a device
or wearable)
Monitored ph
activity (st
distance, heart
Qualitative or mix
methods
@laurawilde2
DA
Thematic synthesis
(Thomas & Harden, 2008)
Coded line by line
Dev
@laurawilde2
THEMES FROM 12 INCLUDED PAPERS
1
Monitoring
keeping
their activity
health
5
Setting
appropriat
achievable
for
condition
2
Suppor
motivation
active
6
Integrating
device
life and
routine
3
Acceptability
the device
7
Perceived
and psychologica
benefits of using
the device
4
Experiencing
technical
with the de
@laurawilde24
1
HEAL
Helpful or useful to mon
increase their physical activity
Keep track and s
or graphs)
Aw
Frus
did not accurat
their activities
“It was neat k
many s
never done that. I
interesting
(Benzo et al., 2018, p. 138)
“My cycling activities
captured by the
(Loeckx et al., 2018,
@laurawilde24
2. SUPPORTING
Encouraged them to do m
tracking their activity and getting
feedback and setting
Having som
‘watching’ their ph
lev
prof
motivat
“W
high motivator
(Subject 02; Larson & Webst
“If you knew someone was wat
from a distance, even if it was once a
fortnight, they w
send you emails and say ‘What
happened?’”
(Participan
@laurawilde24
3. A
Liked t
Not satisfied or did not lik
Overwhelming and daunting
“I was increasing m
lov
(Participant
“My main complaint is about the
armbands and the Garmin.”
(Benzo et al., 2018, p. 13
@laurawilde24
CONCLUSION
Understanding of
experien
Benefits to ph
and mental health
and wellbeing
Further high-quality
in-depth research is
needed
@laurawilde2
THAN
Laura J Wilde
www@laura
And a big thank you to my supervision team Cain Clark, Carol P
ResearchGate has not been able to resolve any citations for this publication.
ResearchGate has not been able to resolve any references for this publication.
Development of a website to improve quality of life for cancer survivors
View project To explore the experiences of people with Chronic Obstructive Pulmonary Disease (COPD) using apps and wearables to monitor physical activity and sedentary behaviour
To explore healthcare practition
ers' experiences and perspectives of supporting people with COPD who have used apps and/or wearables for monitoring their physical activity. ... [more] View project WP1. To develop a culturally acceptable PR intervention that will reduce the disability associated with chronic lung disease. This addresses an unmet need and would make a significant and sustainab
le contribution to the wellbeing of individuals with chronic lung disease. In parallel, we will work with healthcare professionals to ensure that they are able to deliver high quality PR programmes.
WP2. To develop an international, robust and secure PR dataset. This database will ensure a common way to record information about lung disease and rehabilitation, and provide a rich resource for future research projects.
WP3. WPs 1 and 2 will form the basis of WP3: research capacity development. Training will be delivered locally to help health professionals to deliver PR effectively, develop data management and other health research skill. ... [more] View project Article
Full-text available
April 2015 · International Journal of COPD
A substantial proportion of patients with chronic obstructive pulmonary disease (COPD) develops various degree of intrathoracic tracheal collapsibility. We studied whether the magnitude of intrathoracic tracheal collapsibility could be different across clinical phenotypes and sex in COPD. Intrathoracic tracheal collapsibility measured at paired inspiratory-expiratory low dose computed tomography
... [Show full abstract] (CT) and its correlation with clinical, functional, and CT-densitometric data were investigated in 69 patients with COPD according to their predominant conductive airway or emphysema phenotypes and according to sex. Intrathoracic tracheal collapsibility was higher in patients with predominant conductive airway disease (n=28) and in females (n=27). Women with a predominant conductive airway phenotype (n=10) showed a significantly greater degree of collapsibility than women with predominant emphysema (28.9%±4% versus 11.6%±2%; P<0.001). Intrathoracic tracheal collapsibility was directly correlated with inspiratory-expiratory volume variation at CT and with forced expiratory volume (1 second), and inversely correlated with reduced CT lung density and functional residual capacity. Intrathoracic tracheal collapsibility was not correlated with cough and wheezing; however, intrathoracic tracheal collapsibility and clinical phenotypes of COPD are closely correlated. In patients with a predominant emphysematous phenotype, a reduced collapsibility may reflect the mechanical properties of the stiff hyperinflated emphysematous lung. The high collapsibility in patients with predominant airway disease, mild airway obstruction, and in women with this phenotype may reflect chronic airway inflammation. The lack of relationship with such symptoms as wheezing, cough, and dyspnea could indicate that intrathoracic tracheal collapsibility itself should be considered neither an abnormal feature of COPD nor a relevant clinical finding. View full-text Article
Full-text available
April 2021
Coronary obstructive pulmonary disease (COPD) is a reversible incomplete form of advanced airflow obstruction and abnormal inflammation of lung tissues occurred during the progression of this disease. The primary symptoms of this disease involves wheezing phenomena that remain persistent, recurrent chest infectious problems, rest breathlessness that prolongs with exercise, mucus hyper secretion,
... [Show full abstract] consistent coughing with phlegm and ultimately destruction of parenchyma cells of lungs due to severe coughing. In this report, we are discussing the case study of COPD pneumonia patient due to vulnerability of this particular disease. View full-text June 2005 · Revista Brasileira de Medicina
Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic progressive disorder. Among the many goals of clinical therapy are symptoms relief and reduction in the frequency of exacerbations. Formoterol, a potent long-acting β-2 agonist, is used in the treatment of obstructive airway diseases, including COPD. Objectives: To evaluate the effect of formoterol in the treatment of
... [Show full abstract] patients with COPD exacerbation. Casuistic: Patients older than 40 years old presenting a clinical diagnosis of COPD exacerbation for whom Fluir® (formoterol) has been prescribed by the MD were included. The following signs and symptoms were evaluated before and 30 minutes after formoterol administration (12 or 24 mg): dyspnea, cough, thoracic pain and wheezing. Symptoms were scored from 0 to 3, according to their intensity, A global score was obtained by the sum of scores. The frequency of adverse events was reported for safety analysis. Results: Two-hundred and forty patients were included and 154 were considered evaluable. There was a statistically significant improvement in dyspnea, cough and wheezing scores after formoterol administration, while no significant differences were observed in the thoracic pain score. Only 6.2% of the patients presented adverse events possibly or probably related to formoterol. Conclusion: In this observational program, Fluir® was effective and well tolerated in the treatment of COPD exacerbation. Read more June 2007 · Nurse Prescribing
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition that causes the patient to slowly deteriorate over time, with increasing symptoms such as breathlessness, cough, wheeze and production of sputum. To obtain optimal control of symptoms, patients should be prescribed various pharmacological treatments, such as inhaled therapy and oral medication. However, for one reason or
... [Show full abstract] another, as with any chronic illness, a significant proportion of patients fail to take their medication as prescribed. To improve concordance, health professionals need to develop an understanding of patients' reasons for not taking their medication as prescribed. Read more June 2008 · International Journal of COPD
Dyspnea in patients with known chronic obstructive pulmonary disease (COPD) can be a clinical challenge due to the nonspecific nature of atypical presentations. Typical features of fever, productive cough, and wheezing on presentation support COPD exacerbation, while absence of such findings may warrant further evaluation for underlying etiologies, including pulmonary embolism (PE). It is
... [Show full abstract] suspected that one in four patients with atypical COPD exacerbation may have PE as an underlying or concomitant cause of acute dyspnea. This review discusses the clinical presentation of COPD and PE, and presents an overview of the rationale for pursuing work-up for thromboembolic disease in the setting of known obstructive lung diseases. Read more Last Updated: 29 Apr 2022
Interested in research on Chronic Obstructive Pulmonary Disease?
Join ResearchGate to discover and stay up-to-date with the latest research from leading experts in Chronic Obstructive Pulmonary Disease and many other scientific topics.
